Integra Lifesciences Holdings (IART) Leases (2019 - 2025)
Historic Leases for Integra Lifesciences Holdings (IART) over the last 11 years, with Q3 2025 value amounting to $138.2 million.
- Integra Lifesciences Holdings' Leases fell 557.26% to $138.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.2 million, marking a year-over-year decrease of 557.26%. This contributed to the annual value of $144.0 million for FY2024, which is 777.42% down from last year.
- According to the latest figures from Q3 2025, Integra Lifesciences Holdings' Leases is $138.2 million, which was down 557.26% from $136.6 million recorded in Q2 2025.
- In the past 5 years, Integra Lifesciences Holdings' Leases ranged from a high of $156.8 million in Q3 2023 and a low of $81.6 million during Q1 2022
- In the last 5 years, Integra Lifesciences Holdings' Leases had a median value of $145.1 million in 2022 and averaged $130.9 million.
- In the last 5 years, Integra Lifesciences Holdings' Leases crashed by 1045.25% in 2022 and then soared by 7945.47% in 2023.
- Over the past 5 years, Integra Lifesciences Holdings' Leases (Quarter) stood at $84.5 million in 2021, then surged by 75.39% to $148.3 million in 2022, then increased by 5.33% to $156.2 million in 2023, then dropped by 7.77% to $144.0 million in 2024, then dropped by 4.06% to $138.2 million in 2025.
- Its Leases stands at $138.2 million for Q3 2025, versus $136.6 million for Q2 2025 and $138.5 million for Q1 2025.